Carmine Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Carmine Therapeutics's estimated annual revenue is currently $2.5M per year.
- Carmine Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Carmine Therapeutics has 16 Employees.
- Carmine Therapeutics grew their employee count by -54% last year.
Carmine Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP CMC | Reveal Email/Phone |
2 | Associate Director, Analytical Development | Reveal Email/Phone |
3 | Production Specialist | Reveal Email/Phone |
Carmine Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Carmine Therapeutics?
Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads. In June 2020, Carmine inked a research alliance with Takeda Pharmaceuticals worth up to $900 million to develop non-viral gene therapies for 2 targets. Carmine has also been named one of the FierceBiotech’s Fierce 15 Biotech companies of 2020 and was also awarded the Bristol-Myers Squibb "Golden Ticket". Carmine was founded in 2019 by Esco Ventures X, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme and Millennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine. For more information, visit www.carminetherapeutics.com Media Relations [email protected] Investor Relations [email protected]
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-54%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 16 | -16% | $7.1M |
#2 | $3.5M | 16 | -6% | N/A |
#3 | $1M | 16 | N/A | N/A |
#4 | $1.4M | 16 | N/A | N/A |
#5 | $1M | 16 | 7% | N/A |